GUD

Knight Therapeutics

TSX

Add Alert

GUD

Knight Therapeutics

TSX

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

sumotrader Free

01/06/16 2:55 PM

Post #10

Loaded 1600 more shares today. GUD is about to take off.

CommonCents4Dollars Free

03/30/15 9:10 PM

Post #9

This must be some sort of record,.. " the Company reported revenues of $109,608 and net income of $124,981,439."

http://www.gud-knight.com/en/knight-reports-fourth-quarter-and-year-ended-december-31-2014-results

CommonCents4Dollars Free

03/06/15 4:32 PM

Post #8

Knight Therapeutics GUD.TO : Mackie Research starts with buy rating; target price of C$12

http://www.investorvillage.com/groups.asp?mb=6781&mn=83648&pt=msg&mid=14732670

OneStepAhead Free

02/25/15 3:50 PM

Post #7

Re: #6: @CommonCents4Dollars - GOD is GUD. :)

On a tear

CommonCents4Dollars Free

02/25/15 3:11 PM

Post #6

GOD is GUD. :)

CommonCents4Dollars Free

02/24/15 4:21 PM

Post #5

KHTRF is the OTC Ticker for Americans
or
GUD on the TSX for Canadians

LONG on this one.

CommonCents4Dollars Free

02/24/15 4:15 PM

Post #4

GUD is flying along nicely,.. Paladin II is in GUD hands, Goodman building another BEAST!

OneStepAhead Free

12/28/14 1:04 PM

Post #3

GUD Knight Therapeutics

Knight Therapeutics Inc. ("Knight" or the "Company") (TSX:GUD) today announced that it has entered into a bought deal agreement with a syndicate of underwriters led by GMP Securities L.P. and including Cormark Securities Inc., National Bank Financial Inc., Laurentian Bank Securities Inc., Bloom Burton & Co., Clarus Securities Inc., Mackie Research Capital Corporation and TD Securities Inc. (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase 11,111,120 common shares of the Company (the "Common Shares") at a price of $6.75 per Common Share for gross proceeds to Knight of $75,000,060 (the "Offering"). In addition, the Underwriters will have the option, exercisable for a period of 30 days after the closing date, to acquire up to an aggregate of 1,666,668 additional Common Shares ($11,250,009) at the offering price to cover over-allotments, if any (the "Over-Allotment Option"). If the Over-Allotment Option is exercised in full, the total gross proceeds of the Offering shall be $86,250,069.

http://www.marketwired.com/press-release/knight-therapeutics-enters-into-agreement-75-million-bought-deal-common-shares-tsx-gud-1973898.htm

OneStepAhead Free

12/28/14 1:03 PM

Post #2

GUD Knight Therapeutics

After selling off his specialty pharmaceutical company Paladin Labs Inc. in a deal worth $3-billion, Montreal entrepreneur Jonathan Goodman is starting from scratch with a new drug distribution venture.

http://www.theglobeandmail.com/globe-investor/investment-ideas/a-fresh-stock-with-a-veteran-face/article17189152/

Greedy G

12/21/14 11:52 PM

Post #1

TNEN:

http://stockcharts.com/h-sc/ui?s=TNEN&p=D&b=5&g=0&id=p74917584188

Knight Therapeutics (GUD)

Followers	4	Posters	4
Posts (Today)	0	Posts (Total)	10
Created	12/20/14	Type	Free
Moderators

Knight Therapeutics Inc. (TSX: GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products.